Bristol-Myers Squibb: Q2 Earnings Look Like An Inflection Point

JHVEPhoto/iStock Editorial via Getty Images Investment thesis Bristol-Myers Squibb (NYSE:BMY) has just recently released its Q2 earnings, which were very positively absorbed by the market as the stock delivered an 11% rally on Friday after the report went live.  The company delivered a strong quarter with wide positive revenue and EPS surprises. BMY demonstrates exceptional profitability which allows the company to grow through acquisitions, boost innovation, and return cash to shareholders. The stock b ...